Protein kinase C delta mediated cytotoxicity of 6-Hydroxydopamine via sustained extracellular signal-regulated kinase 1/2 activation in PC12 cells

Neurological Research

Volumn 36, Issue 1, 2014, Pages 53-64

  Fan, Ying ^a   Li, Jing ^a   Zhang, Yan Qiao ^a   Jiang, Li Hong ^a   Zhang, Yi Na ^a   Yan, Chao Qi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

6 Hydroxydopamine; Apoptosis; Extracellular signal regulated kinases (ERK); Parkinson's disease; Protein kinase C; Rottlerin; Subtype delta

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXIDOPAMINE; PHORBOL 12 ACETATE 13 MYRISTATE; PROTEIN KINASE C DELTA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DENSITY; CELL GROWTH; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; NICK END LABELING; NONHUMAN; PARKINSON DISEASE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

6-HYDROXYDOPAMINE,; APOPTOSIS,; EXTRACELLULAR SIGNAL-REGULATED KINASES (ERK),; PARKINSON'S DISEASE,; PROTEIN KINASE C,; ROTTLERIN; SUBTYPE DELTA,;

ADRENERGIC AGENTS; ANIMALS; APOPTOSIS; CELL DEATH; CELL SHAPE; CELL SURVIVAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; OXIDOPAMINE; PC12 CELLS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; RATS;

EID: 84892973570     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000267     Document Type: Article

References (55)

1. Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med. 1998;339:1044-53.
2. Benito-Leon J, Bermejo-Pareja F, Morales-Gonzalez JM, Porta-Etessam J, Trincado R, Vega S, et al. Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain. Neurology. 2004;62:734-41.
3. Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science. 2003;302:819-22.
4. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22:153-83.
5. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol. 1968;5:107-10.
6. Alessandrini A, Namura S, Moskowitz MA, Bonventre JV. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci USA. 1999;96:12866-9.
7. Mori T, Wang X, Aoki T, Lo EH. Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury. J Neurotrauma. 2002;19:1411-9.
8. Otani N, Nawashiro H, Fukui S, Nomura N, Yano A, Miyazawa T, et al. Differential activation of mitogen-activated protein kinase pathways after traumatic brain injury in the rat hippocampus. J Cereb Blood Flow Metab. 2002;22:327-34.
9. Kulich SM, Chu CT. Sustained extracellular signal-regulated kinase activation by 6-Hydroxydopamine: implications for Parkinson's disease. J Neurochem. 2001;77:1058-66.
10. Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V. Role of proteolytic activation of protein kinase Cd in oxidative stress-induced apoptosis. Antioxid Redox Signal. 2003;5:609-20.
11. Seth K, Agrawal AK, Aziz MH, Ahmad A, Shukla Y, Mathur N, et al. Induced expression of early response genes/oxidative injury in rat pheochromocytoma (PC12) cell line by 6-Hydroxydopamine: implication for Parkinson's disease. Neurosci Lett. 2002;330:89-93.
12. Zuch CL, Nordstroem VK, Briedrick LA, Hoernig GR, Granholm AC, Bickford PC. Time course of degenerative alterations in nigral dopaminergic neurons following a 6-Hydroxydopamine lesion. J Comp Neurol. 2000;427:440-54.
13. Lane EL, Cheetham S, Jenner P. Dopamine uptake inhibitorinduced rotation in 6-Hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptors. J Pharm Exp Ther. 2005;312:1124-31.
14. Collier TJ, Steece-Collier K, McGuire S, Sortwell CE. Cellular models to study dopaminergic injury responses. Ann N Y Acad Sci. 2003;991:140-51.
15. Cohen G, Heikkila R. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-Hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biol Chem. 1974;249(8):2447-52.
16. Bernstein AI, Garrison SP, Zambetti GP, O'Malley KL. 6-OHDA generated ROS induces DNA damage and p53-and PUMA-dependent cell death. Mol Neurodegener. 2011;6:2.
17. Singh S, Dikshit M. Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide. Brain Res Rev. 2007;54:233-50.
18. Lev N, Melamed E, Offen D. Apoptosis and Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:245-50.
19. Hou ST, Cowan E, Dostanic S, Rasquinha I, Comas T, Morley P, et al. Increased expression of the transcription factor E2F1 during dopamine-evoked, caspase-3-mediated apoptosis in rat cortical neurons. Neurosci Lett. 2001;306:153-6.
20. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol. 2001;65:135-72.
21. Walkinshaw G, Waters CM. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience. 1994;63:975-87.
22. Kolch W. Meaningful relationships: the regulation of the Ras/ Raf/MEK/ERK pathway by protein interactions. Biochem J. 2000;351:289-305.
23. Choi-Lundberg DL, Lin Q, Chang YN, Chiang YL, Hay CM, Mohajeri H, et al. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 1997;275:838-41.
24. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995;270:1326-31.
25. Ishikawa Y, Kitamura M. Dual potential of extracellular signal-regulated kinase for the control of cell survival. Biochem Biophys Res Commun. 1999;264:696-701.
26. Zhu JH, Kulich SM, Oury TD, Chu CT. Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases. Am J Pathol. 2002;161:2087-98.
27. Stanciu M, Wang Y, Kentor R, Burke N, Watkins S, Kress G. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem. 2000;275:12200-6.
28. Kulich SM, Chu CT. Role of reactive oxygen species in extracellular signal-regulated protein kinase phosphorylation and 6-Hydroxydopamine cytotoxicity. J Biosci. 2003;28:3-89.
29. Subramaniam S, Strelau J, Unsicker K. Growth differentiation factor-15 prevents low potassium-induced cell death of cerebellar granule neurons by differential regulation of Akt and ERK pathways. J Biol Chem. 2003;278:8904-12.
30. Kuperstein F, Yavin E. ERK activation and nuclear translocation in amyloid-beta peptide-and iron-stressed neuronal cell cultures. Eur J Neurosci. 2002;16:44-54.
31. Kulich SM, Horbinski C, Patel M, Chu CT. 6-Hydroxydopamine induces mitochondrial ERK activation. Free Radic Biol Med. 2007;43:372-83.
32. Mouatt-Prigent A, Karlsson JO, Agid Y, Hirsch EC. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience. 1996;73:979-87.
33. Glading A, Uberall F, Keyse SM, Lauffenburger DA, Wells A. Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem. 2001;276:23341-8.
34. Tobón-Velasco JC, Limón-Pacheco JH, Orozco-Ibarra M, Macías-Silva M, Vázquez-Victorio G, Cuevas E, et al. 6-OHDA-induced apoptosis and mitochondrial dysfunction are mediated by early modulation of intracellular signals and interaction of Nrf2 and NF-kB factors. Toxicology. 2013;304:109-19.
35. Battaini F. Protein kinase C isoforms as therapeutic targets in nervous system disease states. Pharmacol Res. 2001;44:353-61.
36. Goldberg M, Steinberg SF. Tissue-specific developmental regulation of protein kinase C isoforms. Biochem Pharmacol. 1996;51:1089-93.
37. Liu J, Yang D, Minemoto Y, Leitges M, Rosner MR, Lin A. NF-kappa B is required for UV-induced JNK activation via induction of PKCdelta. Mol Cell. 2006;21:467-80.
38. Kumar S, Bharti A, Mishra NC, Raina D, Kharbanda S, Saxena S, et al. Targeting of the c-Abl tyrosine kinase to mitochondria in the necrotic cell death response to oxidative stress. J Biol Chem. 2001;276:17281-5.
39. Malecki EA. Manganese toxicity is associated with mitochondrial dysfunction and DNA fragmentation in rat primary striatal neurons. Brain Res Bull. 2001;55:225-8.
40. Latchoumycandane C, Anantharam V, Kitazawa M, Yang Y, Kanthasamy A, Kanthasamy AG. Protein kinase Cdelta is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells. J Pharmacol Exp Ther. 2005;313:46-55.
41. Kitazawa M, Anantharam V, Kanthasamy AG. Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration. Neuroscience. 2003;119:945-64.
42. Kikkawa U, Matsuzaki H, Yamamoto T. Protein kinase C delta (PKC delta): activation mechanisms and functions. J Biochem. 2002;132:831-9.
43. Fan Y, Zhang YQ, Sun DJ, Zhang YN, Wu XW, Li J. Rottlerin protected dopaminergic cell line from cytotoxicity of 6-Hydroxydopamine by inhibiting PKCdelta phosphorylation. Neurosci Bull. 2009;25:187-95.
44. Fujii T, García-Bermejo ML, Bernabó JL, Caamaño J, Ohba M, Kuroki T. Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta. J Biol Chem. 2000;275:7574-82.
45. Soltoff SP. Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol Sci. 2007;28:453-8.
46. Gschwendt M, Müller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, et al. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun. 1994;199:93-8.
47. Gschwendt M, Kittstein W, Marks F. Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine. FEBS Lett. 1994;338:85-8.
48. Efimova T, Broome IS, Eckert RL. Protein kinase C delta regulates keratinocyte death and survival by regulating activity and subcellular localization of a p38delta-extracellular signal-regulated kinase 1/2 complex. Mol Cell Biol. 2004; 24:8167-83.
49. Kaul S, Anantharam V, Yang Y, Choi CJ, Kanthasamy A, Kanthasamy AG. Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells. J Biol Chem. 2005;280:28721-30.
50. Yang Y, Kaul S, Zhang D, Anantharam V, Kanthasamy AG. Suppression of caspase-3-dependent proteolytic activation of protein kinase C delta by small interfering RNA prevents MPPz-induced dopaminergic degeneration. Mol Cell Neurosci. 2004;25:406-21.
51. Leverrier S, Vallentin A, Joubert D. Positive feedback of protein kinase C proteolytic activation during apoptosis. Biochem J. 2002;368:905-13.
52. Kaul S, Kanthasamy A, Kitazawa M, Anantharam V, Kanthasamy AG. Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPPz)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. Eur J Neurosci. 2003;18:1387-401.
53. Brodie C, Blumberg PM. Regulation of cell apoptosis by protein kinase c delta. Apoptosis. 2003;8:19-27.
54. Hanrott K, Gudmunsen L, O'Neill MJ, Wonnacott S. 6-Hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta. J Biol Chem. 2006;281:5373-82.
55. 2-treated cells and its activation by tyrosine kinase in vitro. Proc Natl Acad Sci USA. 2001;98:6587-92.